Basic metalloproteinases of the connective tissue matrix
Solov'eva, N.I.
Bioorganicheskaia Khimiia 20(2): 143-152
1994
ISSN/ISBN: 0132-3423 PMID: 8155077 Document Number: 434622
Metalloproteinases play a key role in the destruction of connective tissue matrix both upon normal physiological processes associated with remodelling of connective tissue and in various pathological situations. Variability of the matrix metalloproteinases, their specificity, structural features, activity regulation in vitro and in vivo, as well as their role in processes of oncogenic transformation are reviewed.
Document emailed within 1 workday
Related Documents
Nishimura, K.; Ikebuchi, M.; Kanaoka, Y.; Ohgi, S.; Ueta, E.; Nanba, E.; Ito, H. 2003: Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms International Angiology: a Journal of the International Union of Angiology 22(3): 229-238Ylisirniö, S.; Höyhtyä, M.; Turpeenniemi-Hujanen, T. 2000: Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker Anticancer Research 20(2b): 1311-1316
Sato, T.; Ito, A.; Mori, Y. 1990: Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts Biochemical and Biophysical Research Communications 170(2): 824-829
Akiyama, K.; Shikata, K.; Sugimoto, H.; Matsuda, M.; Shikata, Y.; Fujimoto, N.; Obata, K.; Matsui, H.; Makino, H. 1997: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis Research Communications in Molecular Pathology and Pharmacology 95(2): 115-128
Koizumi, T.; Nakamura, N. 1975: Connective tissue and diseases; 1. Some basic knowledge concerning connective tissue and its constituting elements Nihon Rinsho. Japanese Journal of Clinical Medicine 33(3): 605-609
Woessner, J.F. 1992: Literature on vertebrate matrix metalloproteinases and their tissue inhibitors Matrix (Stuttgart, Germany). Supplement 1: 425-501
Bernal, F.; Hartung, H-Peter.; Kieseier, B.C. 2005: Tissue mRNA expression in rat of newly described matrix metalloproteinases Biological Research 38(2-3): 267-271
Wasilewska, A.; Taranta-Janusz, K.; Zoch-Zwierz, W.; Rybi-Szumińska, A.; Kołodziejczyk, Z. 2009: Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology Przeglad Lekarski 66(9): 485-490
Khimshiashvili, N.B. 2013: Expression of parodontal tissue matrix metalloproteinases-1,2 in adolescent and their role in gingival pathology Georgian Medical News 217: 34-40
Ab Hamid, J.; Mohtarrudin, N.; Osman, M.; Andi Asri, A.A.; Wan Hassan, W.H.; Aziz, R. 2012: Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension Singapore Medical Journal 53(10): 681-683
Moser, P.L.; Hefler, L.; Tempfer, C.; Neunteufel, W.; Kieback, D.G.; Gitsch, G. 1999: Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer Anticancer Research 19(3b): 2365-2367
Ueno, H.; Nakamura, H.; Inoue, M.; Imai, K.; Noguchi, M.; Sato, H.; Seiki, M.; Okada, Y. 1997: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas Cancer Research 57(10): 2055-2060
Piesiak, P.ł; Brzecka, A.; Kosacka, M.; Passowicz-Muszyńska, E.; Dyła, T.; Jankowska, R. 2011: Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 31(185): 270-273
Tsai, H.-C.; Ye, S.-Y.; Kunin, C.M.; Lee, S.S.-J.; Wann, S.-R.; Tai, M.-H.; Shi, M.-H.; Liu, Y.-C.; Chen, Y.-S. 2011: Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis Cytokine 54(2): 109-116
Zhang, J.; Salamonsen, L.A. 2002: In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation Journal of Clinical Endocrinology and Metabolism 87(5): 2346-2351
Okada, Y.; Takeuchi, N.; Gonoji, Y.; Nakanishi, I.; Nagase, H.; Hayakawa, T. 1992: Simultaneous production of collagenase, matrix metalloproteinase 3 (stromelysin) and tissue inhibitor of metalloproteinases by rheumatoid synovial lining cells Matrix . Suppl 1: 398-399
Módis, L. 1978: The molecular structure of the interfibrillar matrix in connective tissue Acta Biologica Academiae Scientiarum Hungaricae 29(3): 197-226
Hiraoka, K.; Sasaguri, Y.; Komiya, S.; Inoue, A.; Morimatsu, M. 1992: Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid synovial fibroblasts Biochemistry International 27(6): 1083-1091
Delektorskaia, V.V.; Smirnova, E.A.; Ponomareva, M.V.; Pavlova, T.V.; Pavlov, I.A. 2010: Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor Arkhiv Patologii 72(4): 3-6
Bruno, C.M.; Valenti, M.; Bertino, G.; Ardiri, A.; Consolo, M.; Mazzarino, C.M.; Amoroso, A.; Neri, S. 2009: Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features Panminerva Medica 51(4): 191-196